Selected Publications (Original Articles)

2021-2025

Lanickova T., Hensler M., Lenka L. et al. Chemotherapy drives tertiary lymphoid structures that correlate with ICI-responsive TCF1+CD8+ T cells in metastatic ovarian cancer. Clin Cancer Res, 2024. IN PRESS 

Sandoval T.A., Salvagno C., Chae C-S. et al. Iron chelation therapy elicits innate immune control of metastatic ovarian cancerCancer Discov, 2024. 14(10): p. 1901-1921.

Saha, S., Ghosh, M., Li, J. et al. Serine depletion promotes anti-tumor immunity by activating mitochondrial DNA-mediated cGAS-STING signaling. Cancer Res, 2024. 84(16): p. 2645-2659.

Kasikova, L., Rakova, J., Hensler, M. et al. Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer. Nat Commun, 2024. 15: p. 2528.

Zhao, L., Liu, P., Mao, M., et al. BCL2 inhibition reveals a dendritic cell-specific immune checkpoint that controls tumor immunosurveillance. Cancer Discov, 2023. 13(11): p. 2448-2469.

Cultrara, C., Uhl, C., Kirby, K., et al. A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma. J Immunother Cancer, 2023. 11(8): p. e006880. 

Sugita, M., Yamazaki, T., Alhomoud, M., et al. Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia. Cell Death Dis, 2023. 14(5): p. 305.

Holicek, P., Truxova, I., Rakova, J. et al. Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients. Cell Death Dis, 2023. 14(3): p. 209.

Klapp, V., Buqué, A., Bloy, N. et al. Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors. J Transl Med, 2023. 21: p. 110.

Clement, C.C., Osran, J., Buqué, A. et al. PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes. Sci Immunol, 2022. 7(74): p. eabl3795.

Fucikova, J., Hensler, M., Kasikova, L. et al. An autologous dendritic cell vaccine promotes anticancer immunity in ovarian cancer patients with low mutational burden and cold tumors. Clin Cancer Res, 2022. 28(14): p. 3053-3065.

Yamazaki, T., Wennerberg, E., Hensler, M. et al. LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. Oncoimmunology, 2021. 10(1): p. e1962592.

Montrose, D.C., Saha, S., Foronda, M. et al. Exogenous and endogenous sources of serine contribute to colon cancer metabolism, growth, and resistance to 5-fluorouracil. Cancer Res, 2021. 81(9): p. 2275-2288.

Morciano, G., Pedriali, G., Bonora, M. et al. A novel naturally occurring mutation in the glycine-rich domain of ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients. Cell Rep, 2021. 35(2): p. 108983.

Clement, C.C., Nanaware, P.P., Yamazaki, T. et al. Pleiotropic consequences of metabolic stressors on the MHC class II antigen processing and presentation machinery. Immunity, 2021. 54(4): p. 721-736.

Petroni, G., Buqué, A., Yamazaki, T. et al. Radiotherapy delivered before CDK4/6 inhibitors mediates superior therapeutic effects in ER+ breast cancer. Clin Cancer Res, 2021. 27(7): p. 1855-1863.

Lhuillier, C., Rudqvist, N.-P., Yamazaki, T. et al. Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control. J Clin Invest, 2021. 131(5): p. e138740.

Rakova, J., Truxova, I., Holicek, P. et al. TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients. Oncoimmunology, 2021. 10(1): p. e1889822.

2016-2020

Yamazaki, T., Kirchmair, A., Sato, A. et al. Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nat Immunol, 2020. 21(10): p. 1160-1171.

Buqué, A., Bloy, N., Perez-Lanzón, M. et al. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nat Comm, 2020. 11(1): p. 3819.

Truxova, I., Kasikova, L., Salek, C. et al. Calreticulin exposure on malignant blasts correlates with improved NK cell-mediated cytotoxicity in AML patients. Haematologica, 2020. 105(7): p. 1868-1878.

Yamazaki, T., Buqué, A., Ames, T.D. et al. PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models. Oncoimmunology, 2020. 9(1): p. e1721810.

Kasikova, L., Hensler, M., Truxova, I. et al. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. J Immunother Cancer, 2019. 7(1): p. 312.

Rodriguez-Ruiz, M.E., Buqué, A., Hensler, M. et al. Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients. Oncoimmunology, 2019. 8(11): p. e1655964.

Bravo-San Pedro, J.M., Sica, V., Martins, I. et al. Acyl-CoA-binding protein is a lipogenic factor that triggers food intake and obesity. Cell Metabol, 2019. 30(4): p. 754-767.e9.

Fucikova, J., Rakova, J., Hensler, M. et al. TIM-3 dictates functional orientation of the immune infiltrate in ovarian cancer. Clin Cancer Res, 2019. 25(15): p. 4820-4831.

Tatsuno, K., Yamazaki, T., Hanlon, D. et al. Extracorporeal photochemotherapy induces bona fide immunogenic cell death. Cell Death Dis, 2019. 29(10): p. 578.

Sica, V., Bravo-San Pedro, J.M., Izzo, V. et al. Lethal poisoning of cancer cells by respiratory chain inhibition plus dimethyl a-ketoglutarate. Cell Rep, 2019. 27(3): p. 820-834.e9.

Pabla, S., Conroy, J.M., Nesline, M.K. et al. Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. J Immunother Cancer, 2019. 7(1): p. 27.

Conroy, J.M., Pabla, S., Nesline, M.K. et al. Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors. J Immunother Cancer, 2019. 7(1): p. 18.

Marchi, S., Corricelli, M., Branchini, A. et al. Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca2+ levels and tumor growth. EMBO J, 2019. 38(2): p. e99435.

Truxova, I., Kasikova, L., Hensler, M. et al. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. J Immunother Cancer, 2018. 6(1): p. 139.

Morrison, C.D., Pabla, S., Conroy, J.M. et al. Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden. J Immunother Cancer, 2018. 6(1): p. 32.

Bonora, M., Morganti, M., Morciano, G. et al. Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation. EMBO Rep, 2017. 18(7): p. 1077-1089.

Fucikova, J., Truxova, I., Hensler, M. et al. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood, 2016. 128(26): p. 3113-3124.

2011-2015

Niso-Santano, M., Malik, S.A., Pietrocola, F. et al. Unsaturated fatty acids induce non-canonical autophagy. EMBO J, 2015. 34(8): p. 1025-1041.

Ma, Y., Mattarollo, S.R., Adjemian, S. et al. CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy. Cancer Res, 2014. 74(2): p. 436-445.

Sukkurwala, A.Q., Martins, I., Wang, Y. et al. Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8. Cell Death Differ, 2014. 21(1): p. 59-68.

Jemaà, M., Galluzzi, L., Kepp, O. et al. Characterization of novel MPS1 inhibitors with preclinical anticancer activity. Cell Death Differ, 2013. 20(11): p. 1532-1545.

Lainey, E., Wolfromm, A., Marie, N. et al. Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia. Oncogene, 2013. 32(37): p. 4331-4342.

Ma, Y., Yamazaki, T., Yang, H. et al. Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy. Oncoimmunology, 2013. 2(6): p. e24786.

Ma, Y., Adjemian, S., Mattarollo, S.R. et al. Anticancer chemotherapy induced intratumoral recruitment and differentiation of antigen presenting cells. Immunity, 2013. 38(4): p. 729-741.

Michels, J., Vitale, I., Galluzzi, L. et al. Cisplatin resistance associated with PARP hyperactivation. Cancer Res, 2013. 73(7): p. 2271-2280.

Bonora, M., Bononi, A., De Marchi, E. et al. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle, 2013. 12(4): p. 674-683.

Shen, S., Niso-Santano, M., Adjemian, S. et al. Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. Mol Cell, 2012. 48(5): p. 667-680.

Senovilla, L., Vitale, I., Martins, I. et al. An immunosurveillance mechanism controls cancer cell ploidy. Science, 2012. 337(6102): p. 1678-1684.

Galluzzi, L., Vitale, I., Senovilla, L. et al. Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Rep, 2012. 2(2): p. 257-269.

Tailler, M., Senovilla, L., Lainey, E. et al. Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia. Oncogene, 2012. 31(30): p. 3536-3546.

Menger, L., Vacchelli, E., Adjemian, S. et al. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med, 2012. 4(143): p. 143ra99.

Jemaà, M., Vitale, I., Kepp, O. et al. Selective killing of p53-deficient cancer cells by SP600125. EMBO Mol Med, 2012. 4(6): p. 500-514.

Michaud, M., Martins, I., Sukkurwala, A.Q. et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science, 2011. 334(6062): p. 1573-1577.

Criollo, A., Niso-Santano, M., Malik, S.A. et al. Inhibition of autophagy by TAB2 and TAB3. EMBO J, 2011. 30(24): p. 4908-4920.

Büttner, S., Ruli, D., Vögtle, F.N. et al. A yeast BH3-only protein mediates the mitochondrial pathway of apoptosis. EMBO J, 2011. 30(14): p. 2779-2792.

Zischka, H., Lichtmannegger, J., Schmitt, S. et al. Mitochondrial membrane crosslinking and destruction in a rat model for Wilson disease. J Clin Invest, 2011. 121(4): p. 1508-1518.

Morselli, E., Mariño, G., Bennetzen, M.V. et al. Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J Cell Biol, 2011. 192(4): p. 615-629.

2006-2010

Vitale, I., Senovilla, L., Jemaà, M. et al. Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos. EMBO J, 2010. 29(7): p. 1272-1284.

Galluzzi, L., Morselli, E., Vitale, I. et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res, 2010. 70(5): p. 1793-1803.

Criollo, A., Senovilla, L., Authier, H. et al. The IKK complex contributes to the induction of autophagy. EMBO J, 2010. 29(3): p. 619-631.

Vicencio, J.M., Ortis, C., Criollo, A. et al. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ, 2009. 16(7): p. 1006-1017.

Boehrer, S., Adès, L., Tajeddine, N. et al. Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome. Oncogene, 2009. 28(22): p. 2205-2218.

Tajeddine, N., Galluzzi, L., Kepp, O. et al. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene, 2008. 27(30): p. 4221-4232.

Hoffmann, J., Vitale, I., Buchmann, B. et al. Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone. Cancer Res, 2008. 68(13): p. 5301-5308.

Tasdemir, E., Maiuri, M.C., Galluzzi, L. et al. Regulation of autophagy by cytoplasmic p53. Nat Cell Biol, 2008. 10(6): p. 676-687.

Pauleau, A.L., Galluzzi, L., Scholz, S.R. et al. Unexpected role of the phosphate carrier in mitochondrial fragmentation. Cell Death Diff, 2008. 15(3): p. 616-618.

Vitale, I., Galluzzi, L., Vivet, S. et al. Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway. PloS ONE, 2007. 2(12): p. e1337.

Zermati, Y., Mouhamad, S., Stergiou, L. et al. Non-apoptotic role for Apaf-1 in the DNA damage checkpoint. Mol Cell, 2007. 28(4): p. 624-637.

De La Motte Rouge, T., Galluzzi, L., Olaussen, K.A. et al. A novel EGFR inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. Cancer Res, 2007. 67(13): p. 6253-6262.

Selected Publications (Review Articles)

2021-2025

Morris, Z.S., Demaria, S., Monjazeb, A.M. et al. Proceedings of the NCI workshop on combining immunotherapy with radiotherapy: Challenges and opportunities for clinical translation. Lancet Oncol. 2025. IN PRESS.

Galassi, C., Chan, T.A., Vitale, I. and Galluzzi, L. The hallmarks of cancer immune evasion. Cancer Cell. 2024. 42(11): p.1825-1863.

Dai, E., Chen, X., Linkermann, A., et al. A guideline on the molecular ecosystem regulating ferroptosis. Nat Cell Biol, 2024. 26(9): p.1447-1457.

De Martino, M., Rathmell, J.C., Galluzzi, L., at al. Cancer-cell metabolism in tumor-targeting immunity. Nat Rev Immunol, 2024. 24(9): p.654-669.

Galluzzi, L., Guilbaud, E., Schmidt, D., et al. Targeting immunogenic cell stress and death for cancer therapy. Nat Rev Drug Discov, 2024. 23(6): p.445-460.

Kroemer, G., Chan, T.A., Eggermont, A.M.M., et al. Immunosurveillance in clinical cancer management. CA Cancer J Clin, 2024. 74(2): p.187-202.

Stern, L.J., Clement, C., Galluzzi, L., et al. Non-mutational neoantigens in disease. Nat Immunol, 2024. 25(1): p. 29-40.

Galluzzi, L., Aryankalayil, MJ., Coleman, CN., et al. Emerging evidence for adapting radiotherapy to immunotherapy. Nat Rev Clin Oncol, 2023. 20(8): p.543-557.

Vitale, I., Pietrocola, F., Guilbaud, E., et al. Apoptotic cell death in disease – Current understanding of the NCCD 2023. Cell Death Differ, 2023. 30(5): p.1097-1154.

Marchi, S., Guilbaud, E., Tait, S.W.G., et al. Mitochondrial control of inflammation. Nat Rev Immunol, 2023. 23(2): p. 159-173.

López-Otín, C., Pietrocola, F., Roiz-Valle, D. et al. Meta-hallmarks of aging and cancer. Cell Metabol, 2023. 35(1): p. 12-35.

Tong, L., Jiménez-Cortegana, C., Tay, A.H.M. et al. NK cells and solid tumors: Therapeutic potential and persisting obstacles. Mol Cancer, 2022. 21(1): p. 206.

Petroni, G., Buqué, A., Coussens, L.M., et al. Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nat Rev Drug Discov, 2022. 22(6): p. 440-462.

Kroemer, G., Galassi, C., Zitvogel, L., et al. Immunogenic cell stress and death. Nat Immunol, 2022. 23(4): p. 487-500.

Petroni, G., Cantley, L.C., Santambrogio, L., et al. Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nat Rev Clin Oncol, 2022. 19(2): p. 114-131.

Klionsly, D.J., Petroni, G., Amaravadi, R.K. et al. Autophagy in major human diseases. EMBO J, 2021. 40(19): p. e108863.

Petroni, G., Buqué, A., Zitvogel, L., et al. Immunomodulation by targeted anticancer agents. Cancer Cell, 2021. 39(3): p. 310-345.

Vitale, I., Shema, E., Loi, S., et al. Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat Med, 2021. 27(2): p. 212-224.

2016-2020

Galluzzi, L., Humeau, J., Buqué, A., et al. Immunostimulation by chemotherapy in the era of immune checkpoint blockers. Nat Rev Clin Oncol, 2020. 17(12): p. 725-741.

Petroni, G., Formenti, S.C., et al. Immunomodulation by anticancer cell cycle inhibitors. Nat Rev Immunol, 2020. 20(11): p. 669-679.

Marchi, S., Giorgi, C., Galluzzi, et al. Ca2+ fluxes and cancer. Mol Cell, 2020. 78(6): p. 1055-1069.

Galluzzi, L., Vitale, I., Warren, S. et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J Immunother Cancer, 2020. 8(1): p. e000337.

Rodriguez-Ruiz, M.E., Vitale, I., Harrington, K.J., et al. Immunological impact of cell death signaling driven by radiation on the tumor microenvironment. Nat Immunol, 2020. 21(2): p. 120-134.

Vanpouille-Box, C., Hoffmann, J.A. and L. Galluzzi. Pharmacological modulation of nucleic acid sensors – Therapeutic potential and persisting obstacles. Nat Rev Drug Discov, 2019. 18(11): p. 845-867.

Deutsch, E., Chargary, C., Galluzzi, L., et al. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy. Lancet Oncol, 2019. 20(8): p. e452-e463.

Galluzzi, L. and D.R. Green. Autophagy-independent functions of the autophagy machinery. Cell, 2019. 177(7): p. 1682-1699.

Vitale, I., Manic, G., Coussens, L.M., et al. Macrophages and metabolism in the tumor microenvironment. Cell Metab, 2019. 30(1): p. 36-50.

Bonora, M., Wieckowski, M.W., Sinclair, D.A. et al. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nat Rev Cardiol, 2019. 16(1): p. 33-55.

Galluzzi, L., Yamazaki, T. and G. Kroemer. Linking intracellular adaptation to stress with organismal homeostasis. Nat Rev Mol Cell Biol, 2018. 19(11): p. 731-745.

Galluzzi, L., Chan, T., Kroemer, G., et al. The hallmarks of successful anticancer immunotherapy. Sci Transl Med, 2018. 10(459): p. eaat7807.

Vanpouille-Box, C., Demaria, S., Formenti, S.C., et al. Cytosolic DNA sensing in organismal tumor control. Cancer Cell, 2018. 34(3): p. 361-378.

Galluzzi, L., Vanpouille-Box, C., Bakhoum, S.F., et al. SnapShot: CGAS-STING signaling. Cell, 2018. 173(1): p. 276–276.e1.

Rybstein, M.D., Bravo-San Pedro, J.M., Kroemer, G., et al. The autophagic network and cancer. Nat Cell Biol, 2018. 20(3): p. 243-251.

Galluzzi, L., Vitale, I., Aaronson, S.A. et al. Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ, 2018. 25(3): p. 486-541.

Carmona-Gutierrez, D., Bauer, M.A., Zimmermann, A. et al. Guidelines and recommendations on yeast cell death nomenclature. Microb Cell, 2018. 5(1): p. 4-31.

Bantug, G., Galluzzi, L., Kroemer, G., et al. The spectrum of T cell metabolism in health and disease. Nat Rev Immunol, 2018. 18(1): p. 19-34.

López-Soto, A., Gonzalez, S., Smyth, M.J., et al. Control of metastases by NK cells. Cancer Cell, 2017. 32(2): p. 135-154.

Galluzzi, L., Baehrecke, E.H., Ballabio, A. et al. Molecular definitions of autophagy and related processes. EMBO J, 2017. 36(13): p. 1811-1836.

Galluzzi, L., Bravo-San Pedro, J.M., Levine, B., et al. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat Rev Drug Discov, 2017. 16(7): p. 487-511.

Vitale, I., Manic, G., De Maria, R., et al. DNA damage in stem cells. Mol Cell, 2017. 66(3): p. 306-319.

Galluzzi, L., Bravo-San Pedro, J.M., Demaria, S., et al. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nat Rev Clin Oncol, 2017. 14(4): p. 247-258.

Galluzzi, L., Bravo-San Pedro, J.M., Demaria, S., et al. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nat Rev Clin Oncol, 2017. 14(4): p. 247-258.

Galluzzi, L., Kepp, O., Chan, F.K, et al. Necroptosis: Mechanisms and relevance to disease. Annu Rev Pathol, 2017. 12: p. 103-130.

Galluzzi, L., Buqué, A., Kepp, O., et al. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol, 2017. 17(2): p. 97-111.

López-Otín, C., Galluzzi, L., Freije, J.M.P., et al. Metabolic control of longevity. Cell, 2016. 166(4): p. 802-821.

Galluzzi, L., Bravo-San Pedro, J.M., Blomgren, K., et al. Autophagy in acute brain injury. Nat Rev Neurosci, 2016. 17(8): p. 467-484.

Galluzzi, L., López-Soto, A., Kumar, S., et al. Caspases connect cell-death signaling to organismal homeostasis. Immunity, 2016. 44(2): p. 221-231.


2011-2015

Galluzzi, L., Buqué, A., Kepp, O., et al. Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell, 2015. 28(6): p. 690-714.

Kroemer, G., Senovilla, L., Galluzzi, L., et al. Natural and therapy-induced immunosurveillance in breast cancer. Nat Med, 2015. 21(10): p. 1128-1138.

Sica, V., Galluzzi, L., Bravo-San Pedro, J.M., et al. Organelle-specific initiation of autophagy. Mol Cell, 2015. 59(4): p. 522-539.

Pietrocola, F., Galluzzi, L., Bravo-San Pedro, J.M., et al. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metabol, 2015. 21(6): p. 805-821.

Zitvogel, L., Galluzzi, L., Kepp, O., et al. Type I interferons in anticancer immunity. Nat Rev Immunol, 2015. 15(7): p. 405-414.

Galluzzi, L., Pietrocola, F., Bravo-San Pedro, J.M. et al. Autophagy in malignant transformation and cancer progression. EMBO J, 2015. 34(7): p. 856-880.

Zitvogel, L., Galluzzi, L., Viaud, S., et al. Cancer and the gut microbiota: An unexpected link. Sci Transl Med, 2015. 7(271): p. 271ps1.

Galluzzi, L., Bravo-San Pedro, J.M., Vitale, I. et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ, 2015. 22(1): p. 58-73.

Galluzzi, L., Vacchelli, E., Bravo-San Pedro, J.M. et al. Classification of current anticancer immunotherapies. Oncotarget, 2014. 5(24): p. 12472-12508.

Kepp, O., Senovilla, L., Vitale, I. et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology, 2014. 3(9): p. e955691.

Galluzzi, L., Pietrocola, F., Levine, B., et al. Metabolic control of autophagy. Cell, 2014. 159(6): p. 1263-1276.

Galluzzi, L., Bravo-San Pedro, J.M. and G. Kroemer. Organelle-specific initiation of cell death. Nat Cell Biol, 2014. 16(8): p. 728-736.

Green, D.R., Galluzzi, L. and G. Kroemer. Metabolic control of cell death. Science, 2014. 345(6203): p. 1250256.

Galluzzi, L., Kepp, O., Vander Heiden, M.G., et al. Metabolic targets for cancer therapy. Nat Rev Drug Discov, 2013. 12(11): p. 829-846.

Ma, Y., Galluzzi, L., Zitvogel, L., et al. Autophagy in cellular immune responses. Immunity, 2013. 39(2): p. 211-227.

Brenner, C., Galluzzi, L., Kepp, O., et al. Decoding cell death signals in liver inflammation. J Hepatol, 2013. 59(3): p. 583-594.

Zitvogel, L., Galluzzi, L., Smyth, M.J., et al. Mechanism of action of conventional and targeted anticancer therapies: Reinstating immunosurveillance. Immunity, 2013. 39(1): p. 74-88.

Kroemer, G., Galluzzi, L., Kepp, O., et al. Immunogenic cell death in cancer therapy. Annu Rev Immunol, 2013. 31: p. 51-72.

Galluzzi, L., Kepp, O. and G. Kroemer. Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol, 2012. 13(12): p. 780-788.

Galluzzi, L., Senovilla, L., Vitale, I. et al. Molecular mechanisms of cisplatin resistance. Oncogene, 2012. 31(15): p. 1869-1883.

Zitvogel, L., Kepp, O., Galluzzi, L., et al. Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol, 2012. 13(4): p. 343-351.

Galluzzi, L., Senovilla, L., Zitvogel, L., et al. The secrete ally: immunostimulation by anticancer drugs. Nat Rev Drug Discov, 2012. 11(3): p. 215-233.

Galluzzi, L., Vitale, I., Abrams, J.M. et al. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ, 2012. 19(1): p. 107-120.

Green, D.R., Galluzzi, L. and G. Kroemer. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science, 2011. 333(6046): p. 1109–1112.

Vitale, I., Galluzzi, L., Castedo, M., et al. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol, 2011. 12(6): p. 385-392.

Kepp, O., Galluzzi, L., Lipinski, M., et al. Cell death assays for drug discovery. Nat Rev Drug Discov, 2011. 10(3): p. 221-237.

2006-2010

Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., et al. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol, 2010. 11(10): p. 700-714.

Fulda, S., Galluzzi, L. and G. Kroemer. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov, 2010. 9(6): p. 447-464.

Galluzzi, L., Blomgren, K. and G. Kroemer. Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci, 2009. 10(7): p. 481-494.

Kroemer, G., Galluzzi, L., Vandenabeele, P. et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ, 2009. 16(1): p. 3-11.

Kroemer, G., Galluzzi, L. and C. Brenner. Mitochondrial membrane permeabilization in cell death. Physiol Rev, 2007. 87(1): p. 99-163.

Independent Commentaries on our Work

Noelle Bell, H. and Zou, W. Cancer Discov. 2024. 14(10): p. 1771-1773.

Borges, F. and A.D. Garg. Cancer Res. 2024. 84(16): p. 2569-2571.

Montes-Gómez, A.E. and S.W.G. Tait. J Transl Med. 2024. 22(1): p. 317. 

Martin S.J. Trends Immunol, 2023. 44(11): p. 871-873.

Booth C.A.G. and A.A. Lane. Trends Cancer, 2023. 9(12):p. 987-988.

Pol, J.G., Plantureux, C., Pérez-Lanzón, M. and G. Kroemer. Oncoimmunology, 2022. 11(1): p. 2130558.

Bird, L. Nat Rev Immunol, 2022. 22(10): p. 594-595.

Newman, J.H. and N. Bhardwaj. Trends Immunol, 2021. 42(4): p. 277-279.

Thorburn, A. Autophagy, 2020. 16(12): p. 2282-2284.

McArthur, K. and Kile B.T. Cell Death Discov, 2020. 6: p. 98.

Garg, A.D. and P. Agostinis. Oncotarget, 2020. 11(36): p. 3352-3353.

Kepp, O. and G. Kroemer. Oncoimmunology, 2020. 9(1): p. 1729022.

Melero, I. et al. Trends Cancer, 2020. 6(3): p. 173-174.

Kesavardhana, S. and T.-D. Kanneganti. Trends Immunol, 2019. 40(12): p. 1073-1075.

De Martino, M. and C. Vanpouille-Box. Trends Cell Biol, 2019. 29(11): p. 851-853.

Chinopoulos, C. EMBO Rep, 2017. 18(7): p. 1041-1042.

Hou, J., Greten. T.F. and Q. Xia. Nat Rev Immunol, 2017. 17(6): p. 401.

Jin, J. and S. He. Nat Rev Immunol, 2017. 17(2): p. 143.

Bankaitis, V.A. EMBO J, 2015. 34(8): p. 978-980.

Ruffell, B. and L. Coussens. Immunity, 2013. 38(4): p. 626-628.

Chinopoulos, C. and G. Szabadkai. Front Oncol, 2013. 3: p. 25.

Mahadevan, N.R. and M. Zanetti. Cell Cycle, 2013. 12(4): p. 544-545.

Alifano, M. and D. Damotte. Cell Cycle, 2013. 12(4): p. 543-544.

Du Toit, A. Nat Rev Mol Cell Biol, 2012. 13(12): p. 754.

Diederich, M. Cell Cycle, 2012. 11(22): p. 4109.

Minton, K. Nat Rev Immunol, 2012. 12(11): p. 745.

Zanetti, M. and N.R. Mahadevan. Science, 2012. 337(6102): p. 1616-1617.

Yao, Z. and G. Szabadkai. Cell Cycle, 2012. 11(20): p. 3721-3722.

Panaretakis, T. Cell Cycle, 2012. 11(20): p. 3723.

Calderón-Montaño, J.M., Burgos-Morón, E. and M. López-Lázaro. Oncogene, 2014. 33(22): p. 2947-2948.

Cianfanelli, V. and F. Cecconi. Cell Cycle, 2012. 11(3): p. 436-437.

Merle, U. and Stremmel W. Hepatology, 2011. 54(1):p. 358-60.

Amaravadi, R.K. Science, 2011. 334(6062): p. 1501-1502.

Gross, A. Cell Death Differ, 2011. 18(10): p. 1543-1544.

Oettinghaus, B., Frank, S. and L. Scorrano. EMBO J, 2011. 30(14): p. 2754-2756.

Chow, K.U. Cell Cycle, 2011. 15(10): p. 3050.

Merle, U. and W. Stremmel. Hepatology, 2011. 54(1): p. 358-360.

Carassa, L. Cell Cycle, 2010. 9(15): p. 2928.

Shieh, S.Y. Cell Cycle, 2010. 9(14): p. 2712.

Levine, B. and J. Abrams. Nat Cell Biol, 2008. 10(6): p. 637-639.

Sanchez-Olea, R and Yuan, J. Mol Cell, 2007. 28(4):p. 520-521.

For a complete list of peer-reviewed publications from Lorenzo Galluzzi, please click here

Highlighted Articles